<DOC>
	<DOCNO>NCT02244554</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy laser tattoo removal picosecond pulse duration compare treatment nanosecond pulse duration use single novel Q-Switched ( QS ) Nd : YAG laser .</brief_summary>
	<brief_title>Comparison Study Picosecond Nanosecond Pulse Durations Using Q-switched Nd : YAG Laser Tattoo Removal</brief_title>
	<detailed_description>This randomize , split-tattoo , open-label , single-center study 25 subject tattoos contain black dark blue ink , alone combination color . It compare safety efficacy nanosecond picosecond pulse duration Cutera Picosecond Q-Switched Nd : YAG laser tattoo removal .</detailed_description>
	<criteria>Females Males , 18 55 year age ( inclusive ) . Fitzpatrick Skin Type I VI . Tattoos contain black/blue ink alone combination color . No tribal , scar , highink density , highly colorful tattoo . Target tattoos old 1 year . Must able read , understand sign Informed Consent Form . Must willing able adhere treatment followup schedule posttreatment care instruction . Wiling cover tattoo bandage clothing ; and/or limited sun exposure use approve sunscreen SPF 50 high treat area start 2 4 week treatment and/or every day duration study , include followup period . Willing use hydroquinone approximately 4 week pretreatment posttreatment require Investigator . Willingness digital photograph take treated area . Agree undergo procedure ( ) tattoo removal study . Postmenopausal surgically sterilize , use medically acceptable form birth control least 3 month prior enrollment entire course study . Participation study another device drug within 6 month prior enrollment study . History allergic reaction pigment follow tattooing . Presence double tattoo treatment area presence tribal , scar , highink density , highly colorful single tattoo . History allergy local anesthetic . History allergy topical antibiotic . History malignant tumor target area . Skin abnormalities target area , e.g. , cut , scrape , wound , scar , large mole . Pregnant and/or breastfeeding . Having infection , dermatitis rash treatment area . Significant concurrent illness , diabetes mellitus cardiovascular disease , e.g. , uncontrolled hypertension . Suffering coagulation disorder take prescription anticoagulation medication . History keloid scarring , hypertrophic scar abnormal wound healing . History immunosuppression/immune deficiency disorder currently use immunosuppressive medication . History vitiligo , eczema , psoriasis . History connective tissue disease , systemic lupus erythematosus scleroderma . History seizure disorder due light . Any use medication know increase sensitivity light accord Investigator 's discretion . History herpes simplex and/or herpes zoster ( shingle ) . History radiation treatment area undergo systemic chemotherapy treatment cancer . History pigmentary disorder , particularly tendency hyper hypopigmentation . Systemic use corticosteroid within 12 month study participation . Use oral isotretinoin within 12 month study participation topical use isotretinoin within 6 month treat area . Anytime life , use gold therapy ( gold salt ) disorder rheumatologic disease lupus . Excessively tanned area treat unable/unlikely refrain tan study . Current smoker history smoking within 6 month study participation . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>tattoo removal</keyword>
	<keyword>Q-switched laser</keyword>
	<keyword>Nd : YAG laser</keyword>
	<keyword>nanosecond laser</keyword>
	<keyword>picosecond laser</keyword>
	<keyword>laser therapy</keyword>
	<keyword>tattoo</keyword>
	<keyword>pulsed-laser</keyword>
	<keyword>laser treatment</keyword>
	<keyword>remove tattoo</keyword>
	<keyword>tattoo clearing</keyword>
	<keyword>tattoo lighten</keyword>
	<keyword>tattoo lighten</keyword>
	<keyword>resistant tattoo</keyword>
</DOC>